| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 8.76e-06 | 372 | 56 | 8 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.43e-05 | 398 | 56 | 8 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 4.89e-05 | 473 | 56 | 8 | GO:0004842 | |
| GeneOntologyMolecularFunction | acyltransferase activity | TRIM64B ZDHHC20 FBXL22 UBE4B UBR5 TRIM21 TRIM64 TADA2A TRIM64C SMURF2 | 5.16e-05 | 775 | 56 | 10 | GO:0016746 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 8.52e-05 | 512 | 56 | 8 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.11e-04 | 532 | 56 | 8 | GO:0016755 | |
| GeneOntologyMolecularFunction | protein kinase binding | TRIM64B SIK1 IRF5 TRIM21 TRIM64 TESK1 TRIM64C ARHGAP33 MAP3K5 | 6.68e-04 | 873 | 56 | 9 | GO:0019901 |
| GeneOntologyMolecularFunction | ubiquitin-ubiquitin ligase activity | 6.88e-04 | 14 | 56 | 2 | GO:0034450 | |
| GeneOntologyMolecularFunction | zinc ion binding | PAPPA2 TRIM64B ZDHHC20 UBR5 LNPEP TRIM21 TRIM64 TADA2A TRIM64C | 7.73e-04 | 891 | 56 | 9 | GO:0008270 |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 1.15e-03 | 18 | 56 | 2 | GO:0086080 | |
| GeneOntologyMolecularFunction | kinase binding | TRIM64B SIK1 IRF5 TRIM21 TRIM64 TESK1 TRIM64C ARHGAP33 MAP3K5 | 1.39e-03 | 969 | 56 | 9 | GO:0019900 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.64e-03 | 83 | 56 | 3 | GO:0015101 | |
| Domain | ConA-like_dom | 3.52e-05 | 219 | 53 | 6 | IPR013320 | |
| Domain | Butyrophylin | 4.61e-05 | 70 | 53 | 4 | IPR003879 | |
| Domain | Neurofascin/L1/NrCAM_C | 4.72e-05 | 4 | 53 | 2 | IPR026966 | |
| Domain | Bravo_FIGEY | 4.72e-05 | 4 | 53 | 2 | PF13882 | |
| Domain | SPRY | 1.08e-04 | 87 | 53 | 4 | SM00449 | |
| Domain | SPRY | 1.46e-04 | 94 | 53 | 4 | PF00622 | |
| Domain | SPRY_dom | 1.46e-04 | 94 | 53 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 1.52e-04 | 95 | 53 | 4 | IPR001870 | |
| Domain | B302_SPRY | 1.52e-04 | 95 | 53 | 4 | PS50188 | |
| Domain | Ubox | 2.19e-04 | 8 | 53 | 2 | SM00504 | |
| Domain | Ubox_domain | 3.50e-04 | 10 | 53 | 2 | IPR003613 | |
| Domain | Rap_GAP | 3.50e-04 | 10 | 53 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 4.27e-04 | 11 | 53 | 2 | IPR000331 | |
| Domain | RAPGAP | 4.27e-04 | 11 | 53 | 2 | PS50085 | |
| Domain | BBOX | 9.90e-04 | 69 | 53 | 3 | SM00336 | |
| Domain | - | 1.08e-03 | 71 | 53 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 1.12e-03 | 72 | 53 | 3 | PF00643 | |
| Domain | ZF_BBOX | 1.52e-03 | 80 | 53 | 3 | PS50119 | |
| Domain | Znf_B-box | 1.57e-03 | 81 | 53 | 3 | IPR000315 | |
| Domain | cEGF | 2.46e-03 | 26 | 53 | 2 | IPR026823 | |
| Domain | cEGF | 2.46e-03 | 26 | 53 | 2 | PF12662 | |
| Domain | HECT | 2.65e-03 | 27 | 53 | 2 | PF00632 | |
| Domain | HECTc | 2.65e-03 | 27 | 53 | 2 | SM00119 | |
| Domain | HECT_dom | 2.65e-03 | 27 | 53 | 2 | IPR000569 | |
| Domain | HECT | 2.65e-03 | 27 | 53 | 2 | PS50237 | |
| Domain | ASX_HYDROXYL | 2.87e-03 | 100 | 53 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.39e-03 | 106 | 53 | 3 | IPR000152 | |
| Domain | EGF_CA | 5.02e-03 | 122 | 53 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.25e-03 | 124 | 53 | 3 | IPR001881 | |
| Domain | EGF | 5.49e-03 | 126 | 53 | 3 | PF00008 | |
| Domain | PRY | 6.33e-03 | 42 | 53 | 2 | PF13765 | |
| Domain | Ldl_recept_a | 7.23e-03 | 45 | 53 | 2 | PF00057 | |
| Domain | - | 7.55e-03 | 46 | 53 | 2 | 4.10.400.10 | |
| Domain | PRY | 8.20e-03 | 48 | 53 | 2 | SM00589 | |
| Domain | LDLRA_1 | 8.20e-03 | 48 | 53 | 2 | PS01209 | |
| Domain | PRY | 8.20e-03 | 48 | 53 | 2 | IPR006574 | |
| Domain | LDLRA_2 | 8.53e-03 | 49 | 53 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 8.53e-03 | 49 | 53 | 2 | IPR002172 | |
| Domain | LDLa | 8.53e-03 | 49 | 53 | 2 | SM00192 | |
| Domain | PX | 8.87e-03 | 50 | 53 | 2 | PS50195 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MST1R SETD1B CELSR3 UBE4B IRF5 SIPA1L2 RALGAPA2 DOCK6 TESK1 SMURF2 ARHGAP33 MAP3K5 | 2.31e-07 | 1105 | 58 | 12 | 35748872 |
| Pubmed | 1.97e-06 | 15 | 58 | 3 | 19703589 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25084355 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8922386 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22378783 | ||
| Pubmed | Human chromosome 11 DNA sequence and analysis including novel gene identification. | 1.00e-05 | 80 | 58 | 4 | 16554811 | |
| Pubmed | Structural and functional evolution of the L1 family: are four adhesion molecules better than one? | 1.64e-05 | 4 | 58 | 2 | 10662501 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11724816 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 7706555 | ||
| Pubmed | The Phox homology (PX) domain, a new player in phosphoinositide signalling. | 2.72e-05 | 5 | 58 | 2 | 11736640 | |
| Pubmed | Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system. | 2.72e-05 | 5 | 58 | 2 | 18022694 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 20188654 | ||
| Pubmed | Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling. | 4.08e-05 | 6 | 58 | 2 | 23897819 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | PAPPA2 HMCN1 UBE4B ERMAP SLC19A2 NFASC GJC2 RUSC1-AS1 SIPA1L2 | 4.93e-05 | 1031 | 58 | 9 | 16710414 |
| Pubmed | 5.15e-05 | 396 | 58 | 6 | 26687479 | ||
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 5.71e-05 | 7 | 58 | 2 | 22579729 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 8672144 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 2341393 | ||
| Pubmed | UBR5 LRP1 MAIP1 TADA2A SIPA1L2 RALGAPA2 ARHGAP33 WDR62 ALG13 | 9.05e-05 | 1116 | 58 | 9 | 31753913 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 29773651 | ||
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 30836988 | ||
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 25653379 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.09e-04 | 55 | 58 | 3 | 19468303 | |
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 1.78e-04 | 12 | 58 | 2 | 16701205 | |
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 19652017 | ||
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 36379255 | ||
| Pubmed | A large family of endosome-localized proteins related to sorting nexin 1. | 3.66e-04 | 17 | 58 | 2 | 11485546 | |
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 12461558 | ||
| Pubmed | 3.94e-04 | 85 | 58 | 3 | 19028597 | ||
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 20602751 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 4.59e-04 | 19 | 58 | 2 | 22144910 | |
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 37422473 | ||
| Pubmed | 5.90e-04 | 407 | 58 | 5 | 12693553 | ||
| Pubmed | Cytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6. | 6.18e-04 | 22 | 58 | 2 | 24981174 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 6.34e-04 | 100 | 58 | 3 | 25807483 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 8.00e-04 | 25 | 58 | 2 | 2283726 | |
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 32266943 | ||
| Pubmed | 8.28e-04 | 251 | 58 | 4 | 27507650 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 8.66e-04 | 26 | 58 | 2 | 26949039 | |
| Pubmed | 8.66e-04 | 26 | 58 | 2 | 8218172 | ||
| Pubmed | 8.89e-04 | 446 | 58 | 5 | 24255178 | ||
| Pubmed | 9.34e-04 | 27 | 58 | 2 | 34709416 | ||
| Pubmed | 1.00e-03 | 28 | 58 | 2 | 35474067 | ||
| Pubmed | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | 1.31e-03 | 32 | 58 | 2 | 23535730 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 1.46e-03 | 742 | 58 | 6 | 26871637 | |
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 1.57e-03 | 35 | 58 | 2 | 16939646 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 9.04e-05 | 95 | 45 | 4 | 59 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.82e-03 | 37 | 45 | 2 | 454 | |
| GeneFamily | Ring finger proteins | 4.78e-03 | 275 | 45 | 4 | 58 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.48e-03 | 161 | 45 | 3 | 593 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.51e-06 | 187 | 58 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 189 | 58 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 189 | 58 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | (000)_CD14+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 5.81e-06 | 197 | 58 | 5 | cff498bc7b153f28dd013eaeb73ead4fb62fb44c | |
| ToppCell | (00)_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 5.95e-06 | 198 | 58 | 5 | 2252e756a8a25d32c16a723e833c1390a772c2a4 | |
| ToppCell | (0)_Myeloid|World / immune cells in Peripheral Blood (logTPM normalization) | 5.95e-06 | 198 | 58 | 5 | aca971ee9d6801bea52288d86b44defa9e306969 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.25e-06 | 200 | 58 | 5 | 107a0665fb20247511a430178effd7630a619488 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.25e-06 | 200 | 58 | 5 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-05 | 141 | 58 | 4 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-05 | 141 | 58 | 4 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-05 | 161 | 58 | 4 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 5.77e-05 | 161 | 58 | 4 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-05 | 168 | 58 | 4 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 169 | 58 | 4 | d2def7229fe9d6b0c70cfed349ede491c8c137a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.32e-05 | 177 | 58 | 4 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 8.32e-05 | 177 | 58 | 4 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-05 | 179 | 58 | 4 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 179 | 58 | 4 | f3f9c7e575bc4d9d3bce649b90254182e8f6aaec | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 179 | 58 | 4 | 01e0b49e7f03ac9c3e6c34708ead300d27236b8b | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-05 | 183 | 58 | 4 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-05 | 184 | 58 | 4 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.87e-05 | 185 | 58 | 4 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 188 | 58 | 4 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 188 | 58 | 4 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 190 | 58 | 4 | a273fc119baebc11020009c923beafeebb6428c9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 190 | 58 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 190 | 58 | 4 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.09e-04 | 190 | 58 | 4 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 190 | 58 | 4 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.12e-04 | 191 | 58 | 4 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | 24ebc8d4a9fc3782510162e04fe586f7cb371eed | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.14e-04 | 192 | 58 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 58 | 4 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 58 | 4 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 58 | 4 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 193 | 58 | 4 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 193 | 58 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 193 | 58 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 193 | 58 | 4 | d845beb0915a5b4bbd1e8f9b8d9322527a822849 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.16e-04 | 193 | 58 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-04 | 194 | 58 | 4 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.19e-04 | 194 | 58 | 4 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.19e-04 | 194 | 58 | 4 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.21e-04 | 195 | 58 | 4 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-04 | 195 | 58 | 4 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.21e-04 | 195 | 58 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 195 | 58 | 4 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 195 | 58 | 4 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 1.23e-04 | 196 | 58 | 4 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | f0b106078212be1d0938f545707a004a1e830857 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 196 | 58 | 4 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 196 | 58 | 4 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | (7)_MNP-(7)_Monocyte|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.23e-04 | 196 | 58 | 4 | 4c2ea16352ba3482c02c03866460e0d975f9fc99 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 196 | 58 | 4 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 196 | 58 | 4 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | IIH-granulo1-|IIH / Condition, Cell_class and T cell subcluster | 1.26e-04 | 197 | 58 | 4 | 51be6d5652b17c70f3a33f244efc3b728ec56f5b | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.26e-04 | 197 | 58 | 4 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-04 | 197 | 58 | 4 | a1d42d0177630e08f36a96a6272f796244c1a319 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-04 | 197 | 58 | 4 | 6e96a6c2576f52b72aeab1e41f47a0af05ff327a | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.26e-04 | 197 | 58 | 4 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-04 | 197 | 58 | 4 | a80be1081f3ed0aceea69a33be21bca6bc354472 | |
| ToppCell | IIH-granulo1|IIH / Condition, Cell_class and T cell subcluster | 1.26e-04 | 197 | 58 | 4 | 39637e8b726bc58c0a6885c49713111f97aff881 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-04 | 197 | 58 | 4 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | (0)_Myeloid-(00)_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.28e-04 | 198 | 58 | 4 | 9c17589ef0f6583c4c106c06936877fd74c258ce | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.28e-04 | 198 | 58 | 4 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 198 | 58 | 4 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | 5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 198 | 58 | 4 | d7e15e61b6018e4c36461c9471ee29601929925c | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD14_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.28e-04 | 198 | 58 | 4 | 128969698b2b0468cf5374f695e2d9fd02227d13 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.28e-04 | 198 | 58 | 4 | 5b31b6e008e05d6528656114fbe0ccae8ffe13b1 | |
| ToppCell | Control-Myeloid-CD14_Mono|Control / Disease, Lineage and Cell Type | 1.28e-04 | 198 | 58 | 4 | c8d88671d47b87a101749b3f4ab90a28f9b6bc72 | |
| ToppCell | control-Classical_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.31e-04 | 199 | 58 | 4 | 171ccbd498774911143d55a27feeec745a0a7122 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 199 | 58 | 4 | 4fc03377c017209111561789226621d258291481 | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.31e-04 | 199 | 58 | 4 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | Healthy/Control-Classical_Monocyte|World / Disease group and Cell class | 1.31e-04 | 199 | 58 | 4 | 527c767a09f911e319f7ad230b6518cebc0f367d | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.31e-04 | 199 | 58 | 4 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 1.31e-04 | 199 | 58 | 4 | ea1e2ccde3930fab6d04a9bf130837455c742474 | |
| ToppCell | Healthy_donor-Classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 1.31e-04 | 199 | 58 | 4 | af3a80dbf5e0306b80f420fd41f1aaed81fe9c46 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.31e-04 | 199 | 58 | 4 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | Healthy/Control-Classical_Monocyte|Healthy/Control / Disease group and Cell class | 1.31e-04 | 199 | 58 | 4 | 4e8c7445d32fd2b7a50524dcd52141e76850c3df | |
| ToppCell | control-Myeloid-CD14_Monocytes_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.31e-04 | 199 | 58 | 4 | 8c14237c3da91d1a4878df489a495408a1e83883 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-CD14+_Monocyte|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | 172244415387e35747573c1b0a89b7e6fa7d1942 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 58 | 4 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | control-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.33e-04 | 200 | 58 | 4 | 251ca08fab5cc2a4e280db6a6286a9ebaef3e61a | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.33e-04 | 200 | 58 | 4 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 6.51e-06 | 194 | 54 | 6 | 5303_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; HL60; HG-U133A | 7.32e-06 | 198 | 54 | 6 | 1970_DN | |
| Disease | MASA syndrome (implicated_via_orthology) | 7.38e-05 | 7 | 56 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Drug habituation | 1.38e-03 | 115 | 56 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.38e-03 | 115 | 56 | 3 | C0236969 | |
| Disease | Drug abuse | 1.38e-03 | 115 | 56 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.38e-03 | 115 | 56 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.38e-03 | 115 | 56 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.38e-03 | 115 | 56 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.38e-03 | 115 | 56 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.38e-03 | 115 | 56 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.38e-03 | 115 | 56 | 3 | C4316881 | |
| Disease | Substance abuse problem | 1.41e-03 | 116 | 56 | 3 | C0740858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YDFRPFPACSFAPAA | 241 | Q96EY9 | |
| FPSCHAFFPLPLTPT | 186 | Q9NP73 | |
| DGLSPCFFFTLVPST | 21 | Q9NP58 | |
| FSCSPRYGIFAPPSR | 536 | Q8N3C7 | |
| PPTFPGCQGFFRDFI | 561 | Q8IWY9 | |
| LPAAFASFPACPQRS | 81 | Q8WWC4 | |
| PALLDCAFFGSPLPT | 471 | Q92823 | |
| GFEVRPFFPCSRQPC | 236 | Q5T442 | |
| PDGESCRSLDPFKPF | 1256 | Q07954 | |
| LFFGPCVFNSLRPST | 241 | Q8NGF9 | |
| AGAATTSCYPPFLPF | 551 | Q9Y239 | |
| PLAARSAFPCFDEPA | 296 | Q9UIQ6 | |
| QTNTPPPFEIFFCFG | 386 | Q13568 | |
| HCPPRFFSLGFPGFS | 1061 | Q2PPJ7 | |
| FISLTCEVSGFPPPD | 2981 | Q96RW7 | |
| PRGFPFVPPSRFFSA | 106 | Q6MZM9 | |
| FVPPSRFFSAAAAPA | 111 | Q6MZM9 | |
| EFPSCSFQPKAPVFG | 46 | P17482 | |
| DCPFFGSPIPTLRWF | 451 | O94856 | |
| PEPTSDTCGFTRFPG | 786 | Q9BXP8 | |
| SFCFPRPHFSFSTLP | 1661 | Q96QU1 | |
| GFFSPAPRECLPPFL | 1031 | O14559 | |
| GLRTFLFCTPFTPDG | 1846 | Q96HP0 | |
| FPYERRPTSAACIPF | 206 | Q7Z4J2 | |
| PTCRTPGVFDPGYRF | 516 | P15586 | |
| NAPKRPPSGFFLFCS | 91 | O15347 | |
| PPSGFFLFCSEFRPK | 96 | O15347 | |
| IPSYSRGFLPCTPRF | 76 | Q9ULL0 | |
| PRCEVAARSFPPSSF | 1511 | Q9NYQ7 | |
| GFFASLRPSEPFLTP | 41 | O60779 | |
| LGHTPFIFSLPFCGP | 156 | Q96KK4 | |
| FSVPPFAPSGFCTIP | 11 | Q99683 | |
| NFSGPLRPFFEPCLH | 386 | Q96PL5 | |
| PPPFFLCLQCFTRGF | 36 | O75478 | |
| PSSFAPAGKSLCFRP | 356 | Q86WR7 | |
| SFRASTFHPFLQCPP | 161 | Q8N699 | |
| RTRVCPPTFPGADAF | 231 | Q6P050 | |
| VPFGFPEFFRCDPAI | 226 | Q9P2F8 | |
| PLFFPVDASCSGVFR | 416 | A0A0B4J2F2 | |
| PLFFPVDASCSGVFR | 416 | P57059 | |
| PGRDFSFTPTFSEPS | 1426 | Q9UPS6 | |
| PAFSVFCHPPRGFDI | 221 | Q66K80 | |
| TRFAPFLPESFCGSP | 156 | Q8NBR9 | |
| FCGSPLPSEQSSRPF | 166 | Q8NBR9 | |
| PASEYSSPGRPLSCF | 191 | Q9HAU4 | |
| LSRGFFSREPICPFE | 6 | Q8N587 | |
| PIFSSLGDGCSFPTR | 281 | Q5W0Z9 | |
| PPFSEPKFPTECFFL | 746 | O95155 | |
| PLFPSCFAPYAASRL | 146 | Q9UM01 | |
| TFSGTVRPICLPFFD | 301 | Q9NRS4 | |
| QRSFFLPPFSGATPS | 36 | P48067 | |
| FSFGFLSMCPRPTPA | 576 | Q15569 | |
| CAFTGPLRPFFSPGF | 436 | P19474 | |
| CPLTFHPSFFPPVEG | 136 | Q86TA4 | |
| APRFATSLPHFPGCA | 1016 | O43379 | |
| FPFFVPSSSPFPFSR | 186 | Q8N895 | |
| GFPPSSFSSPLRPFF | 431 | A6NLI5 | |
| FPPSSFSSPLRPFFC | 431 | A6NGJ6 | |
| PPGPFDSLEESRAFC | 216 | P57768 | |
| FPPSSFSSPLRPFFC | 431 | A6NI03 | |
| RGLDFFQSPSFCPNP | 396 | Q04912 | |
| PQRAPSGERSFFCPD | 421 | Q7Z7K2 | |
| SEGPPLTSFRPQCSF | 2161 | O95071 | |
| PSFFCLAASPASRPA | 71 | Q6UXR8 |